ARTICLE | Distillery Therapeutics
Boosting OSM and TIMP1 levels to treat demyelinating diseases
February 28, 2020 9:27 PM UTC
INDICATION: Multiple sclerosis (MS)...
BCIQ Company Profiles
INDICATION: Multiple sclerosis (MS)...
BCIQ Company Profiles
BCIQ Company Profiles